Nighttime dexmedetomidine for delirium prevention in non-mechanically ventilated patients after cardiac surgery (MINDDS): A single-centre, parallel-arm, randomised, placebo-controlled superiority trial.

Qu JZ, Mueller A, McKay TB, Westover MB, Shelton KT, Shaefi S, D'Alessandro DA, Berra L, Brown EN, Houle TT, Akeju O, MINDDS Study Team

Open source

DOI
10.1016/j.eclinm.2022.101796
Published
2023 Feb
Container
EClinicalMedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2022.101796,
  title = {Nighttime dexmedetomidine for delirium prevention in non-mechanically ventilated patients after cardiac surgery (MINDDS): A single-centre, parallel-arm, randomised, placebo-controlled superiority trial.},
  author = {Qu JZ and Mueller A and McKay TB and Westover MB and Shelton KT and Shaefi S and D'Alessandro DA and Berra L and Brown EN and Houle TT and Akeju O and MINDDS Study Team},
  year = {2023},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2022.101796},
  url = {https://doi.org/10.1016/j.eclinm.2022.101796}
}

RIS

TY  - JOUR
TI  - Nighttime dexmedetomidine for delirium prevention in non-mechanically ventilated patients after cardiac surgery (MINDDS): A single-centre, parallel-arm, randomised, placebo-controlled superiority trial.
AU  - Qu JZ
AU  - Mueller A
AU  - McKay TB
AU  - Westover MB
AU  - Shelton KT
AU  - Shaefi S
AU  - D'Alessandro DA
AU  - Berra L
AU  - Brown EN
AU  - Houle TT
AU  - Akeju O
AU  - MINDDS Study Team
PY  - 2023
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2022.101796
UR  - https://doi.org/10.1016/j.eclinm.2022.101796
ER  - 

APA

JZ, Q., A, M., TB, M., MB, W., KT, S., S, S., DA, D., L, B., EN, B., TT, H., O, A., & Team, M. S. (2023). Nighttime dexmedetomidine for delirium prevention in non-mechanically ventilated patients after cardiac surgery (MINDDS): A single-centre, parallel-arm, randomised, placebo-controlled superiority trial.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2022.101796

Source records